Brief: Intercept Pharmaceuticals posts Q1 sales USD 68 million
27/04/2023 12:21
Apr 27 (Reuters) - Intercept Pharmaceuticals Q1 sales USD 68 million. * Q1 operating expenses USD 93.6 million * Q1 net income USD -31.9 million
Recent news on Intercept Pharmaceuticals
See all newsIntercept Pharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Digitalbridge Group, Huntington Ingalls Industries, Workday
U.S. RESEARCH ROUNDUP-Docusign, Immunovant, Liberty Energy
U.S. STOCKS ON THE MOVE-Amazon, United Parcel Service, Nike
U.S. STOCKS ON THE MOVE-BullFrog AI, Soleno,